Activin and Inhibin

Haspin-IN-3 (compound 8l) is a potent haspin inhibitor with IC 50 of 14 nM. Haspin-IN-3 has anticancer effectsForm:SolidIC50&amp: Target:IC50: 14 nM (Haspin).

HBF-0259 is a potent and selective inhibitor of hepatitis B virus (HBV) surface antigen (HBsAg) secretion, with an EC 50 of 1.5 μM in HepG2.2.15 cells. HBF-0259 has no effect on HBV DNA synthesis.In VitroHBF-0259 (0.0158-50.0 μM) inhibits the HBsAg

HBF-0259 is a potent and selective inhibitor of hepatitis B virus (HBV) surface antigen (HBsAg) secretion, with an EC 50 of 1.5 μM in HepG2.2.15 cells. HBF-0259 has no effect on HBV DNA synthesis.In VitroHBF-0259 (0.0158-50.0 μM) inhibits the HBsAg

HBF-0259 is a potent and selective inhibitor of hepatitis B virus (HBV) surface antigen (HBsAg) secretion, with an EC 50 of 1.5 μM in HepG2.2.15 cells. HBF-0259 has no effect on HBV DNA synthesis.In VitroHBF-0259 (0.0158-50.0 μM) inhibits the HBsAg

HBV-IN-4, a phthalazinone derivative, is a potent and orally active HBV DNA replication inhibitor with an IC 50 of 14 nM. HBV-IN-4 induces the formation of genome-free capsids and has potent anti- HBV potenciesIn VitroHBV-IN-4 (compound 19f: 0-1 μM:

HBV-IN-4, a phthalazinone derivative, is a potent and orally active HBV DNA replication inhibitor with an IC 50 of 14 nM. HBV-IN-4 induces the formation of genome-free capsids and has potent anti- HBV potenciesIn VitroHBV-IN-4 (compound 19f: 0-1 μM:

HBV-IN-4, a phthalazinone derivative, is a potent and orally active HBV DNA replication inhibitor with an IC 50 of 14 nM. HBV-IN-4 induces the formation of genome-free capsids and has potent anti- HBV potenciesIn VitroHBV-IN-4 (compound 19f: 0-1 μM:

HBV-IN-4, a phthalazinone derivative, is a potent and orally active HBV DNA replication inhibitor with an IC 50 of 14 nM. HBV-IN-4 induces the formation of genome-free capsids and has potent anti- HBV potenciesIn VitroHBV-IN-4 (compound 19f: 0-1 μM:

HBV-IN-4, a phthalazinone derivative, is a potent and orally active HBV DNA replication inhibitor with an IC 50 of 14 nM. HBV-IN-4 induces the formation of genome-free capsids and has potent anti- HBV potenciesIn VitroHBV-IN-4 (compound 19f: 0-1 μM:

HBV-IN-4, a phthalazinone derivative, is a potent and orally active HBV DNA replication inhibitor with an IC 50 of 14 nM. HBV-IN-4 induces the formation of genome-free capsids and has potent anti- HBV potenciesIn VitroHBV-IN-4 (compound 19f: 0-1 μM:

hCAII-IN-8, an amide, is a highly selective carbonic anhydrase (CA) inhibitor with an IC 50 value of 0.18 μM against hCA IIIn VitrohCAII-IN-8 (compound 9: 100 μM: 24-48 h) has noncytotoxic on HEK-293 T cells (cell viability&gt:90%) compared to the

hCAII-IN-8, an amide, is a highly selective carbonic anhydrase (CA) inhibitor with an IC 50 value of 0.18 μM against hCA IIIn VitrohCAII-IN-8 (compound 9: 100 μM: 24-48 h) has noncytotoxic on HEK-293 T cells (cell viability&gt:90%) compared to the